Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Small peptide ALK-3 agonist demonstrates regenerative potential in kidney

March 29, 2012

Nymox reports new data from follow-up study of NX-1207

March 28, 2012

Astellas Pharma files MAA for new fixed-dose combination tablet for LUTS

March 27, 2012

EMA to review Vivus' MAA for avanafil in ED

March 26, 2012

Novel mineralocorticoid receptor antagonists presented by KBP BioSciences

March 15, 2012

FDA accepts CRTX-080 NDA for filing

March 14, 2012

KBP BioSciences reports new mineralocorticoid receptor antagonists

March 8, 2012

Scientists in Brazil identify new phosphodiesterase 5 inhibitors

March 8, 2012

Phase II trial of CTP-499 advances

March 7, 2012

Solabegron demonstrates efficacy in phase II study

Feb. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...